340B Drug Pricing Program
AHA, others challenge Novartis in court filings to defend Mississippi’s 340B contract pharmacy law .
AHA, others challenge PhRMA in court filings to defend Mississippi’s 340B contract pharmacy law.
Johnson & Johnson Nov. 12 filed a lawsuit against the Department of Health and Human Services and the Health Resources and Services Administration asking a federal court in Washington, D.C., to declare J&J’s proposed 340B rebate model legal and block the government’s attempts to prohibit…
Johnson & Johnson yesterday filed a lawsuit against the Department of Health and Human Services and the Health Resources and Services Administration asking a federal court in Washington, D.C., to declare J&J’s proposed 340B rebate model legal and block the government’s attempts to prohibit…
The AHA Nov. 7 filed a friend-of-the-court brief in the U.S. District Court for the District of Kansas in defense of the state's law protecting against deceptive acts or practices related to 340B pricing for contract pharmacy arrangements.
AHA amicus brief defending Kansas’ 340B Contract Pharmacy Law in ABBVIE INC., et al., case.
AHA releases Regulatory Advisory summarizing CMS final guidance on implementation of the Medicare Drug Price Negotiation Program
The Centers for Medicare & Medicaid Services (CMS) Oct. 2 released its final guidance on implementing the Inflation Reduction Act’s (IRA) Medicare Drug Price Negotiation Program.
The AHA, 340B Health, the Minnesota Hospital Association and American Society of Health-System Pharmacists Oct. 4 filed two amicus briefs in the U.S. District Court for the District of Minnesota, defending the state's law protecting 340B pricing for contract pharmacy arrangements.
The AHA, 340B Health, the Minnesota Hospital Association and American Society of Health-system Pharmacists Oct. 4 filed an amicus brief in the U.S. District Court for the District of Minnesota, defending the state's law protecting 340B pricing for contract pharmacy arrangements.